EnhancerAtlas 2.0: an updated resource with typical enhancer annotation in 600 tissue/cell types across nine species
EnhancerAtlas 2.0
TagContent
EnhancerAtlas ID
HS182-10111 
Organism
Homo sapiens 
Tissue/cell
Spleen 
Coordinate
chr17:78247740-78249460 
Target genes
TF binding sites/motifs
Number: 20             
TFJASPAR IDCoordinateMotif SequenceStrand-Log10(p-value)
RREB1MA0073.1chr17:78248382-78248402CTGTGGGGGGTGAGTGGGGT-6.13
RREB1MA0073.1chr17:78248534-78248554CTGTGGGGGGTGAGTGGGGT-6.13
RREB1MA0073.1chr17:78248644-78248664GTGGGGTGTGTGTTGGGGGG-6.13
RREB1MA0073.1chr17:78248697-78248717TGGGGGTGTGTGAGTGGGGT-6.15
RREB1MA0073.1chr17:78248721-78248741GTGGGGTGTGTGTGTTGGGT-6.15
RREB1MA0073.1chr17:78248863-78248883TGGGGGTGTGTGAGTGGGGT-6.15
RREB1MA0073.1chr17:78248825-78248845GGTGTGTGTGTGTTGGGGGT-6.17
RREB1MA0073.1chr17:78248490-78248510CTGGGGGGGGTGAGTGGGGT-6.24
RREB1MA0073.1chr17:78248642-78248662GAGTGGGGTGTGTGTTGGGG-6.28
RREB1MA0073.1chr17:78248404-78248424GTGTGGGGGGTGAGTGGGGT-6.45
RREB1MA0073.1chr17:78248468-78248488GTGTGGGGGGTGAGTGGGGT-6.45
RREB1MA0073.1chr17:78248512-78248532GTGTGGGGGGTGAGTGGGGT-6.45
RREB1MA0073.1chr17:78248848-78248868TGTTGGTGTGTGAGTTGGGG-6.63
RREB1MA0073.1chr17:78248620-78248640CTGTGGGGGGTGAGTGGGGG-6.64
RREB1MA0073.1chr17:78248682-78248702GGGATGTGTGTGTGTTGGGG-6.74
RREB1MA0073.1chr17:78248887-78248907TGGGTGTGTGTGTGTTGGGT-6.94
RREB1MA0073.1chr17:78248872-78248892GTGAGTGGGGTGTGTTGGGT-6
RREB1MA0073.1chr17:78248823-78248843GGGGTGTGTGTGTGTTGGGG-7.54
RREB1MA0073.1chr17:78248749-78248769GGGGGGTGTGTGTGTTGGGG-7.68
ZNF740MA0753.2chr17:78248428-78248441GTGGGGGGTGTGG-6.03
Number of super-enhancer constituents: 5             
IDCoordinateTissue/cell
SE_15364chr17:78246173-78249465CD4_Memory_Primary_7pool
SE_18860chr17:78247616-78248418CD4p_CD25-_Il17-_PMAstim_Th
SE_18860chr17:78248639-78249535CD4p_CD25-_Il17-_PMAstim_Th
SE_19614chr17:78247566-78248479CD4p_CD25-_Il17p_PMAstim_Th17
SE_53776chr17:78248679-78249387Spleen
Diseases: AD,Huntington,Obesity,Parkinson,Prostate cancer,Schizophrenia and Sleep disorder
Number of disease enhancers: 2             
ChromosomeStartEnd
chr177824807278248460
chr177824864278248738
Number: 1             
IDChromosomeStartEnd
GH17I080272chr177824612378249535
Enhancer Sequence
CAGACCCAAT ACTCGTGTGT CTCCCAGAAG CTGTGGCTGG GGTGGGGCCT GAGCTTCTGC 60
CGTGTGTATC TGTGTCCCAA GCTTCTGTGG GTCTCTTTGC ATTGAGGGTG CAAGCTCAGA 120
GGTGCCTTGC TGCTTCGGGG CAGGGACCTG AGCGTCCGCT GGGTGCGTGT CTTGCGCTTC 180
TGTAGGCCTC TGCATTGAGG GTGCGTGCCC AGAGGGGCTT TGAAGCTTTG GGTGTGGGGT 240
GGGTGCTCTG GAAATGTGCT GGCTGGCAGG TTACCCTTCT TGGAAGGGTA TGGCTGAGCC 300
ACCTTTTGGC TCCCTCTGGC CTTGAACAGC CTCTTAGGCG TTAGACACCA AGAGAATGCG 360
TCCTTGTTAA GATTCCCAGT TGGAGCACTA GGCGAGGCTT TCGAGGGGAG CGTCCTGGAC 420
ATGTTCAAGG AGAATGGTTG GAAGAGAAGG GCTCCTGGGC TCTAGCGCGG CCTGGGAAGA 480
CCCAGAGGGC AGTGTCAGCT CCCGGGTTTC TTGCTGGGCA CGGAGAAGGG GAAGCTGTCT 540
TTCTGTGTCT GCACTGGGGC TGGCTTTCTG TCTGTCGTTC CTTGTAGGTG GCACTCCATG 600
GTTGGGCTAT GGTGGGAAGT GATGCAGCCG CAGTGCTGTG GTCTGTGGGG GGTGAGTGGG 660
GTGAGTGTGG GGGGTGAGTG GGGTGTCTGT GGGGGGTGTG GGGTGAGTGT GTGGGGTGAG 720
TGGGGTGAGT GTGGGGGGTG AGTGGGGTGT CTGGGGGGGG TGAGTGGGGT GAGTGTGGGG 780
GGTGAGTGGG GTGTCTGTGG GGGGTGAGTG GGGTGAGTGT GGGGTGTGAG TGGGGTGTCT 840
GTGGGGGATG AGTGGGGTGA GTGGGGGGTG AGGGGGGTGT CTGTGGGGGG TGAGTGGGGG 900
GTGAGTGGGG TGTGTGTTGG GGGGTGTGTG AGTGGTGTGA ATGGGATGTG TGTGTGTTGG 960
GGGTGTGTGA GTGGGGTGTG AGTGGGGTGT GTGTGTTGGG TGTGTGAGTG GGGGGTGTGT 1020
GTGTTGGGGT GTGTGTGTTG GATGTGTGTG TATGTGTTGG GGTATGTGAG TTGGTGTGTG 1080
AGTGGGGTGT GTGTGTGTTG GGGGTGTGTG TTGGTGTGTG AGTTGGGGGT GTGTGAGTGG 1140
GGTGTGTTGG GTGTGTGTGT GTTGGGTGTG TGCGTGTTGG GTGTGTGTGA GTGGTGTGTG 1200
TGTGTTGGGA GTGTGTGTGG GGTGAGTGGG ATGTGTGTGT ATGTTGGGGT GTGTGGGAGT 1260
GGGGTGTGTG TGTGCTTGTG TCATTCCCTT GGAGAATAAT CCCTTCCAGA GCAGCCAAGG 1320
CCACCCCCAA GCCTGGAGCA CATGGGATGC GGAAGGTTTG GGTAACTCCC TTTTTATGCC 1380
TAATTTGGAA CTCTGTCAGA GTGGGAAAGT GGCAGTACGG ATGGTGTTCC TTGAAAACAT 1440
TGAAGGCAAA TGAATAAACC CTTTGCCATC TGGGGCAAAC AATAAACCCG CCCAAAGACA 1500
GAGGAAAAGC TAAGAATTGA GTTACTTGGG GGAATAAAAT TTTGAAAAGT TTCCATGAAT 1560
AATGAGGAAT CTAGAAAGCC ACACAAATGC TCGAGCAGGA CGCACTCGAA AAAGACCTGA 1620
GAAGACCTCA GTGCAGGCTG GAAGGAAGGC TGAGTGTGGG AGGAGTGTCC CAACTCAGGG 1680
CCAGTCTACA GAGACTGAGA GAGTATTATT TTTTCTTTAT 1720